片仔癀又做LP

Core Viewpoint - Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. announced its participation in the CICC Medical Fund, focusing on investments in the healthcare sector, particularly in traditional Chinese medicine, biomedicine, medical devices, and related industries [1] Group 1 - The CICC Medical Fund aims to raise a total of 1 billion RMB, with Zhangzhou Pien Tze Huang Investment Management Co., Ltd. committing to invest 200 million RMB, representing 20% of the fund's target size [1] - The fund will primarily invest in projects related to the Pien Tze Huang industry chain, Pien Tze Huang industrial park, and other projects that attract investment to Zhangzhou [1] - The investment strategy aligns with the growing trend in the healthcare sector, emphasizing the importance of traditional Chinese medicine and related health services [1]